tirzepatide semaglutide weight loss vs for Tirzepatide outperformed semaglutide weight-loss drug

Elbadawy NN, Saad MA, Elfarrash S, Ahmed MAE, Abdelkader NF (2025) The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization

Scientific references National Center for Biotechnology Information

[Crossref] [PubMed] NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee

It does this as a dual receptor agonist, which means it works on both gastric inhibitory polypeptide (GIP hormones) and GLP-1 receptors in the body

Acta Biomed

SWOT Snapshot (Quick Take): Strength: First-in-class weekly insulin with strong efficacy Weakness: Limited dosing flexibility vs daily insulin Opportunity: Adherence-driven market expansion & GLP-1 combos Threat: Physician inertia + competitive long-acting pipelines